Page last updated: 2024-12-08
cyclocolorenone
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
cyclocolorenone: sesquiterpenoid isolated from the liverwort, Plagiochila acanthophylla subsp. japonica; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Plagiochila acanthophylla | species | [no description available] | Plagiochilaceae | [no description available] |
Cross-References
ID Source | ID |
---|---|
PubMed CID | 160491 |
MeSH ID | M0050222 |
Synonyms (6)
Synonym |
---|
489-45-2 |
cyclocolorenone |
6h-cycloprop(e)azulen-6-one, 1,1a,2,3,4,4a,5,7b-octahydro-1,1,4,7-tetramethyl-, (1ar-(1aalpha,4alpha,4abeta,7balpha))- |
Q67879817 |
1,1,4,7-tetramethyl-1,1a,2,3,4,4a,5,7b-octahydro-6h-cyclopropa[e]azulen-6-one |
DTXSID20964135 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.34
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.34) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |